Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Endocrine Peptide Test Market Report 2024

Endocrine Peptide Test Global Market Report 2025 – By Test-Type (Dehydroepiandrosterone Sulphate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Oestradiol, Human Chorionic Gonadotropin, Thyroid-Stimulating Hormone, Other Test-Types), By Technology (Mass Spectroscopy, Immunoassay, Chromatography, Nucleic Acid Based, Other Technologies), By End-User (Clinics, Healthcare Centers, Hospitals, Commercial Laboratories) – Market Size, Trends, And Global Forecast 2025-2034

Endocrine Peptide Test Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Endocrine Peptide Test Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Endocrine Peptide Test Market Definition

Endocrine peptide test refers to a diagnostic test used to measure the levels of specific peptides (small proteins) in the blood or urine that are related to the functioning of the endocrine system. The primary aim of the endocrine peptide test is to diagnose and monitor endocrine disorders by measuring specific peptide hormones in the blood.

The main types of tests in endocrine peptide test market are dehydroepiandrosterone sulphate, progesterone, luteinizing hormone, thyroid prolactin, oestradiol, human chorionic gonadotropin, thyroid-stimulating hormone, and others. The dehydroepiandrosterone sulfate (DHEAS) test is a blood test that measures the levels of DHEAS in the body. The various technologies include mass spectroscopy, immunoassay, chromatography, nucleic acid based, and others. The end users are clinics, healthcare centers, hospitals, and commercial laboratories.

Endocrine Peptide Test Market Segmentation

The endocrine peptide test market covered in this report is segmented –

1) By Test-Type: Dehydroepiandrosterone Sulphate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Oestradiol, Human Chorionic Gonadotropin, Thyroid-Stimulating Hormone, Other Test-Types

2) By Technology: Mass Spectroscopy, Immunoassay, Chromatography, Nucleic Acid Based, Other Technologies

3) By End-User: Clinics, Healthcare Centers, Hospitals, Commercial Laboratories

Subsegments:

1) By Dehydroepiandrosterone Sulphate (DHEA-S): Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)

2) By Progesterone: Immunoassay Tests, Chemiluminescence Assays, ELISA Tests

3) By Luteinizing Hormone (LH): Immunoassay Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (RIA)

4) By Thyroid Prolactin: Immunoassay Tests, Chemiluminescence Assays, Radioimmunoassay (RIA)

5) By Oestradiol: Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)

6) By Human Chorionic Gonadotropin (hCG): Immunoassay Tests, Chemiluminescence Assays, Enzyme Immunoassay (EIA)

7) By Thyroid-Stimulating Hormone (TSH): Immunoassay Tests, Radioimmunoassay (RIA), Enzyme-Linked Immunosorbent Assay (ELISA)

8) Other Test-Types: Cortisol, Insulin, Growth Hormone (GH), Parathyroid Hormone (PTH)

Endocrine Peptide Test Market Size and growth rate 2025 to 2029: Graph

Endocrine Peptide Test Market Size 2025 And Growth Rate

The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to $9.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing government spending, rising prevalence of diabetes, decreasing level of immunity in people across the world, high risk of contracting any chronic diseases, and rising government initiatives.

Endocrine Peptide Test Market Growth Forecast

The endocrine peptide test market size is expected to see strong growth in the next few years. It will grow to $14.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for endocrine peptide test, growth in research and development activities, rise in number of lifestyle diseases, increasing geriatric population, and rising prevalence of diabetes amongst the masses. Major trends in the forecast period include advancement in the endocrine testing method, advancements in product technologies, increasing research and development activities to develop novel testing solutions, growing number of product approval, and shift towards preventive healthcare.

Book your 30 minutes free consultation with our research experts

Contact Us

Endocrine Peptide Test Market Driver: Impact of Diabetes Prevalence on Endocrine Peptide Test Market Growth

The rising prevalence of diabetes is expected to propel the growth of the endocrine peptide test market going forward. Diabetes refers to a group of diseases that result in high blood sugar (glucose) levels. The prevalence of diabetes is increasing due to factors such as unhealthy diets, sedentary lifestyles, genetic predisposition, and an aging population. Endocrine peptide test, including hemoglobin A1c, fasting plasma glucose, and C-peptide tests, is used in diabetes to diagnose the condition, monitor glucose levels, and assess insulin production and sensitivity. For instance, in June 2024, according to the National Health Service (NHS), UK-based government department, the number of individuals under 40 diagnosed with diabetes increased significantly, rising from 173,166 in 2022 to 216,440 in 2023. This sharp growth underscores a concerning trend of rising diabetes prevalence in younger populations. Therefore, the rising prevalence of diabetes is driving the endocrine peptide test market.

Global Endocrine Peptide Test Market Major Players

Major companies operating in the endocrine peptide test market are Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories

Global Endocrine Peptide Test Market Trend: Advancements in Immunoassay Testing Systems for Endocrine Peptide Testing

Major companies operating in the endocrine peptide test market are developing immunoassay testing systems to improve endocrine peptide testing accuracy, sensitivity, and speed. These testing systems use antibodies to detect and measure specific peptides in blood or urine samples, providing healthcare professionals with valuable information about hormone levels and endocrine function. For instance, in July 2023, Siemens Healthineers, a German-based healthcare services company, launched Atellica CI Analyzer, a compact system for immunoassay and clinical chemistry testing, including endocrine peptide assays. The analyzer also features a reproductive endocrinology menu that includes anti-Mullerian hormone (AMH) to determine ovarian reserve and sFlt-1 and PlGF (placental growth factor) to aid in the prognosis of preeclampsia. The Atellica CI Analyzer is designed to deliver quality results quickly and consistently, with up to 1000 tests per hour capacity. It provides workflow efficiency and flexibility to help labs meet evolving testing needs.

Endocrine Peptide Test Market Merger And Acquisition: Tolmar Pharmaceuticals Inc. Acquired JATENZO From Clarus Therapeutics Holdings Inc

In October 2022, Tolmar, a US-based pharmaceutical company acquired Jatenzo from Clarus Therapeutics for an undisclosed amount. Through this acquisition, Jatenzo, a testosterone replacement therapy, complements Tolmar's focus on pediatric endocrinology and men's health, enhancing their portfolio of specialty pharmaceutical products. Clarus Therapeutics is a US-based pharmaceutical company focused on developing and commercializing therapies for people with endocrine disorders.

Regional Outlook For The Global Endocrine Peptide Test Market

North America was the largest region in the endocrine peptide test market in 2024. The regions covered in the endocrine peptide test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine peptide test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Endocrine Peptide Test Market?

The endocrine peptide test market includes revenues earned by entities by providing services such as diagnostic testing, laboratory analysis, research studies, and clinical evaluations. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine peptide test market also includes sales of diagnostic kits, reagents, testing instruments, and laboratory equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Endocrine Peptide Test Industry?

The endocrine peptide test market research report is one of a series of new reports from The Business Research Company that provides endocrine peptide test market statistics, including the endocrine peptide test industry global market size, regional shares, competitors with endocrine peptide test market share, detailed endocrine peptide test market segments, market trends, and opportunities, and any further data you may need to thrive in the endocrine peptide test industry. These endocrine peptide test market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Endocrine Peptide Test Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $9.97 billion
Revenue Forecast In 2034 $14.22 billion
Growth Rate CAGR of 9.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Test-Type: Dehydroepiandrosterone Sulphate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Oestradiol, Human Chorionic Gonadotropin, Thyroid-Stimulating Hormone, Other Test-Types
2) By Technology: Mass Spectroscopy, Immunoassay, Chromatography, Nucleic Acid Based, Other Technologies
3) By End-User: Clinics, Healthcare Centers, Hospitals, Commercial Laboratories Subsegments: 1) By Dehydroepiandrosterone Sulphate (DHEA-S): Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
2) By Progesterone: Immunoassay Tests, Chemiluminescence Assays, ELISA Tests
3) By Luteinizing Hormone (LH): Immunoassay Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (RIA)
4) By Thyroid Prolactin: Immunoassay Tests, Chemiluminescence Assays, Radioimmunoassay (RIA)
5) By Oestradiol: Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) 6) By Human Chorionic Gonadotropin (hCG): Immunoassay Tests, Chemiluminescence Assays, Enzyme Immunoassay (EIA) 7) By Thyroid-Stimulating Hormone (TSH): Immunoassay Tests, Radioimmunoassay (RIA), Enzyme-Linked Immunosorbent Assay (ELISA) 8) Other Test-Types: Cortisol, Insulin, Growth Hormone (GH), Parathyroid Hormone (PTH)
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Endocrine Peptide Test Market Characteristics

    3. Endocrine Peptide Test Market Trends And Strategies

    4. Endocrine Peptide Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Endocrine Peptide Test Growth Analysis And Strategic Analysis Framework

    5.1. Global Endocrine Peptide Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Endocrine Peptide Test Market Growth Rate Analysis

    5.4. Global Endocrine Peptide Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Endocrine Peptide Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Endocrine Peptide Test Total Addressable Market (TAM)

    6. Endocrine Peptide Test Market Segmentation

    6.1. Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Dehydroepiandrosterone Sulphate

    Progesterone

    Luteinizing Hormone

    Thyroid Prolactin

    Oestradiol

    Human Chorionic Gonadotropin

    Thyroid-Stimulating Hormone

    Other Test-Types

    6.2. Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Mass Spectroscopy

    Immunoassay

    Chromatography

    Nucleic Acid Based

    Other Technologies

    6.3. Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Clinics

    Healthcare Centers

    Hospitals

    Commercial Laboratories

    6.4. Global Endocrine Peptide Test Market, Sub-Segmentation Of Dehydroepiandrosterone Sulphate (DHEA-S), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Immunoassay Tests

    Enzyme-Linked Immunosorbent Assay (ELISA)

    Radioimmunoassay (RIA)

    6.5. Global Endocrine Peptide Test Market, Sub-Segmentation Of Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Immunoassay Tests

    Chemiluminescence Assays

    ELISA Tests

    6.6. Global Endocrine Peptide Test Market, Sub-Segmentation Of Luteinizing Hormone (LH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Immunoassay Tests

    Enzyme Immunoassay (EIA)

    Radioimmunoassay (RIA)

    6.7. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid Prolactin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Immunoassay Tests

    Chemiluminescence Assays

    Radioimmunoassay (RIA)

    6.8. Global Endocrine Peptide Test Market, Sub-Segmentation Of Oestradiol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Immunoassay Tests

    Enzyme-Linked Immunosorbent Assay (ELISA)

    Radioimmunoassay (RIA)

    6.9. Global Endocrine Peptide Test Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Immunoassay Tests

    Chemiluminescence Assays

    Enzyme Immunoassay (EIA)

    6.10. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid-Stimulating Hormone (TSH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Immunoassay Tests

    Radioimmunoassay (RIA)

    Enzyme-Linked Immunosorbent Assay (ELISA)

    6.11. Global Endocrine Peptide Test Market, Sub-Segmentation Of Other Test-Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cortisol

    Insulin

    Growth Hormone (GH)

    Parathyroid Hormone (PTH)

    7. Endocrine Peptide Test Market Regional And Country Analysis

    7.1. Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Endocrine Peptide Test Market

    8.1. Asia-Pacific Endocrine Peptide Test Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Endocrine Peptide Test Market

    9.1. China Endocrine Peptide Test Market Overview

    9.2. China Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Endocrine Peptide Test Market

    10.1. India Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Endocrine Peptide Test Market

    11.1. Japan Endocrine Peptide Test Market Overview

    11.2. Japan Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Endocrine Peptide Test Market

    12.1. Australia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Endocrine Peptide Test Market

    13.1. Indonesia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Endocrine Peptide Test Market

    14.1. South Korea Endocrine Peptide Test Market Overview

    14.2. South Korea Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Endocrine Peptide Test Market

    15.1. Western Europe Endocrine Peptide Test Market Overview

    15.2. Western Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Endocrine Peptide Test Market

    16.1. UK Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Endocrine Peptide Test Market

    17.1. Germany Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Endocrine Peptide Test Market

    18.1. France Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Endocrine Peptide Test Market

    19.1. Italy Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Endocrine Peptide Test Market

    20.1. Spain Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Endocrine Peptide Test Market

    21.1. Eastern Europe Endocrine Peptide Test Market Overview

    21.2. Eastern Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Endocrine Peptide Test Market

    22.1. Russia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Endocrine Peptide Test Market

    23.1. North America Endocrine Peptide Test Market Overview

    23.2. North America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Endocrine Peptide Test Market

    24.1. USA Endocrine Peptide Test Market Overview

    24.2. USA Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Endocrine Peptide Test Market

    25.1. Canada Endocrine Peptide Test Market Overview

    25.2. Canada Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Endocrine Peptide Test Market

    26.1. South America Endocrine Peptide Test Market Overview

    26.2. South America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Endocrine Peptide Test Market

    27.1. Brazil Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Endocrine Peptide Test Market

    28.1. Middle East Endocrine Peptide Test Market Overview

    28.2. Middle East Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Endocrine Peptide Test Market

    29.1. Africa Endocrine Peptide Test Market Overview

    29.2. Africa Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Endocrine Peptide Test Market Competitive Landscape And Company Profiles

    30.1. Endocrine Peptide Test Market Competitive Landscape

    30.2. Endocrine Peptide Test Market Company Profiles

    30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

    31. Endocrine Peptide Test Market Other Major And Innovative Companies

    31.1. Laboratory Corporation of America Holdings (LabCorp)

    31.2. Quest Diagnostics Incorporated

    31.3. Agilent Technologies Inc.

    31.4. Illumina Inc.

    31.5. bioMérieux SA

    31.6. Bio-Rad Laboratories Inc.

    31.7. DiaSorin S.p.A.

    31.8. Sciex

    31.9. Bio-Techne Corporation

    31.10. Invitae Corporation

    31.11. ARUP Laboratories

    31.12. Genova Diagnostics

    31.13. Boston Heart Diagnostics Corporation

    31.14. Immunodiagnostic Systems Ltd.

    31.15. Mayo Clinic Laboratories

    32. Global Endocrine Peptide Test Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Endocrine Peptide Test Market

    34. Recent Developments In The Endocrine Peptide Test Market

    35. Endocrine Peptide Test Market High Potential Countries, Segments and Strategies

    35.1 Endocrine Peptide Test Market In 2029 - Countries Offering Most New Opportunities

    35.2 Endocrine Peptide Test Market In 2029 - Segments Offering Most New Opportunities

    35.3 Endocrine Peptide Test Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Endocrine Peptide Test Market, Sub-Segmentation Of Dehydroepiandrosterone Sulphate (DHEA-S), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Endocrine Peptide Test Market, Sub-Segmentation Of Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Endocrine Peptide Test Market, Sub-Segmentation Of Luteinizing Hormone (LH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid Prolactin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Endocrine Peptide Test Market, Sub-Segmentation Of Oestradiol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Endocrine Peptide Test Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid-Stimulating Hormone (TSH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Endocrine Peptide Test Market, Sub-Segmentation Of Other Test-Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Siemens AG Financial Performance
  • Table 83: F. Hoffmann-La Roche AG Financial Performance
  • Table 84: Thermo Fisher Scientific Inc. Financial Performance
  • Table 85: Merck KGaA Financial Performance
  • Table 86: Becton Dickinson and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Endocrine Peptide Test Market, Sub-Segmentation Of Dehydroepiandrosterone Sulphate (DHEA-S), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Endocrine Peptide Test Market, Sub-Segmentation Of Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Endocrine Peptide Test Market, Sub-Segmentation Of Luteinizing Hormone (LH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid Prolactin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Endocrine Peptide Test Market, Sub-Segmentation Of Oestradiol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Endocrine Peptide Test Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid-Stimulating Hormone (TSH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Endocrine Peptide Test Market, Sub-Segmentation Of Other Test-Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Siemens AG Financial Performance
  • Figure 83: F. Hoffmann-La Roche AG Financial Performance
  • Figure 84: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 85: Merck KGaA Financial Performance
  • Figure 86: Becton Dickinson and Company Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

Biosimilar Therapeutic Peptides Global Market Report 2025 – By Type (Innovative, Generic), By Route Of Administration (Parenteral Route, Transdermal Route, Other Route Of Administrations), By Application (Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Peptide Therapeutics Global Market Report 2025 – By Type (Generic, Branded), By Route of Administration (Parenteral, Mucosal, Oral, Transdermal), By Application (Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Peptide Antibiotics Global Market Report 2025 – By Type (Ribosomal Synthesized Peptide Antibiotics, Non-ribosomal Synthesized Peptide Antibiotics), By Drugs (Daptomycin, Dalbavancin, Telavancin, Other Drugs), By Disease Outlook (Skin Infection, HABP/VABP, Blood Stream Infection, Other Diseases), By Distribution Channel (Hospitals, Homecare, Specialty Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Glycopeptide Antibiotics Global Market Report 2025 – By Drug (Vancomycin, Dalbavancin, Oritavancin, Other Drugs), By Route of Administration (Oral, Parenteral, Other Routes), By Indication (Skin And Structure Infection, Meningitis, Clostridioides Difficile Infection, Enterocolitis, Other Indications), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Glucagon-like Peptide 1 Global Market Report 2025 – By Product (Trulicity, Ozempic, Victoza, Rybelsus, Other Types), By Route of Administration (Oral, Parenteral, Other Routes), By End-Users (Hospitals, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Peptide Synthesis Global Market Report 2025 – By Product And Service (Reagents, Equipment, Services), By Technology (Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology), By End User (Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Food Safety Testing Global Market Report 2025 – By Contaminant (Pathogens, Pesticides, Genetically Modified Organisms (GMOs), Toxins, Others Containments), By Technology (Traditional, Rapid), By Application (Meat, Poultry, And Seafood Products, Dairy And Dairy Products, Processed Food, Beverages, Cereals And Grains) – Market Size, Trends, And Global Forecast 2025-2034

View Report

C-Reactive Protein Testing Global Market Report 2025 – By Assay Type (Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays), By Application (Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications ), By End Use (Clinics, Hospitals, Diagnostic Laboratories) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Endocrine Peptide Test market?

Endocrine peptide test refers to a diagnostic test used to measure the levels of specific peptides (small proteins) in the blood or urine that are related to the functioning of the endocrine system. The primary aim of the endocrine peptide test is to diagnose and monitor endocrine disorders by measuring specific peptide hormones in the blood. For further insights on the Endocrine Peptide Test market, request a sample here

How will the Endocrine Peptide Test market drivers and restraints affect the market dynamics? What forces will shape the Endocrine Peptide Test industry going forward?

The Endocrine Peptide Test market major growth driver - Impact of Diabetes Prevalence on Endocrine Peptide Test Market Growth. For further insights on the Endocrine Peptide Test market, request a sample here

What is the forecast market size or the forecast market value of the Endocrine Peptide Test market?

The Endocrine Peptide Test market size has grown strongly in recent years. The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to $9.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing government spending, rising prevalence of diabetes, decreasing level of immunity in people across the world, high risk of contracting any chronic diseases, and rising government initiatives. The endocrine peptide test market size is expected to see strong growth in the next few years. It will grow to $14.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for endocrine peptide test, growth in research and development activities, rise in number of lifestyle diseases, increasing geriatric population, and rising prevalence of diabetes amongst the masses. Major trends in the forecast period include advancement in the endocrine testing method, advancements in product technologies, increasing research and development activities to develop novel testing solutions, growing number of product approval, and shift towards preventive healthcare. For further insights on the Endocrine Peptide Test market, request a sample here

How is the Endocrine Peptide Test market segmented?

The endocrine peptide test market covered in this report is segmented –
1) By Test-Type: Dehydroepiandrosterone Sulphate, Progesterone, Luteinizing Hormone, Thyroid Prolactin, Oestradiol, Human Chorionic Gonadotropin, Thyroid-Stimulating Hormone, Other Test-Types
2) By Technology: Mass Spectroscopy, Immunoassay, Chromatography, Nucleic Acid Based, Other Technologies
3) By End-User: Clinics, Healthcare Centers, Hospitals, Commercial Laboratories
Subsegments:
1) By Dehydroepiandrosterone Sulphate (DHEA-S): Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
2) By Progesterone: Immunoassay Tests, Chemiluminescence Assays, ELISA Tests
3) By Luteinizing Hormone (LH): Immunoassay Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (RIA)
4) By Thyroid Prolactin: Immunoassay Tests, Chemiluminescence Assays, Radioimmunoassay (RIA)
5) By Oestradiol: Immunoassay Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
6) By Human Chorionic Gonadotropin (hCG): Immunoassay Tests, Chemiluminescence Assays, Enzyme Immunoassay (EIA)
7) By Thyroid-Stimulating Hormone (TSH): Immunoassay Tests, Radioimmunoassay (RIA), Enzyme-Linked Immunosorbent Assay (ELISA)
8) Other Test-Types: Cortisol, Insulin, Growth Hormone (GH), Parathyroid Hormone (PTH) For further insights on the Endocrine Peptide Test market, request a sample here

Which region has the largest share of the Endocrine Peptide Test market? What are the other regions covered in the report?

North America was the largest region in the endocrine peptide test market in 2024. The regions covered in the endocrine peptide test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Endocrine Peptide Test market, request a sample here.

Who are the major players in the Endocrine Peptide Test market?

Major companies operating in the endocrine peptide test market are developing immunoassay testing systems to improve endocrine peptide testing accuracy, sensitivity, and speed. These testing systems use antibodies to detect and measure specific peptides in blood or urine samples, providing healthcare professionals with valuable information about hormone levels and endocrine function. For instance, in July 2023, Siemens Healthineers, a German-based healthcare services company, launched Atellica CI Analyzer, a compact system for immunoassay and clinical chemistry testing, including endocrine peptide assays. The analyzer also features a reproductive endocrinology menu that includes anti-Mullerian hormone (AMH) to determine ovarian reserve and sFlt-1 and PlGF (placental growth factor) to aid in the prognosis of preeclampsia. The Atellica CI Analyzer is designed to deliver quality results quickly and consistently, with up to 1000 tests per hour capacity. It provides workflow efficiency and flexibility to help labs meet evolving testing needs.. For further insights on the Endocrine Peptide Test market, request a sample here.

What are the key trends in the Endocrine Peptide Test market?

Major trends in the Endocrine Peptide Test market include Advancements in Immunoassay Testing Systems for Endocrine Peptide Testing. For further insights on the Endocrine Peptide Test market, request a sample here.

What are the major opportunities in the Endocrine Peptide Test market? What are the strategies for the Endocrine Peptide Test market?

For detailed insights on the major opportunities and strategies in the Endocrine Peptide Test market, request a sample here.

How does the Endocrine Peptide Test market relate to the overall economy and other similar markets?

For detailed insights on Endocrine Peptide Test's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Endocrine Peptide Test industry?

For detailed insights on the mergers and acquisitions in the Endocrine Peptide Test industry, request a sample here.

What are the key dynamics influencing the Endocrine Peptide Test market growth? SWOT analysis of the Endocrine Peptide Test market.

For detailed insights on the key dynamics influencing the Endocrine Peptide Test market growth and SWOT analysis of the Endocrine Peptide Test industry, request a sample here.